TFAP2A and breast cancer: So far, TFAP2A-AS1 has been reported to be key prognostic lncRNA in clear cell renal cell carcinoma [9] and to inhibit cell proliferation and invasion in breast cancer via miR-933/SMAD2 axis [10].